Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Stott

Showing results (301-310 of 423) with videos related to

Pageof 43
Sort By:
Pathogens (Basel, Switzerland)|April 30, 2021
Cytokine, Chemokine, and Metalloprotease Activation in the Serum of Patients with Nephropathia Epidemica from the Republic of Tatarstan and the Republic of Mordovia, RussiaEkaterina Martynova, Yuriy Davidyuk, Emmanuel Kabwe, et al.
European Journal of Clinical Pharmacology|December 22, 2015
Non-response to (statin) therapy: the importance of distinguishing non-responders from non-adherers in pharmacogenetic studiesS Trompet, I Postmus, P E Slagboom, et al.
BMC Geriatrics|February 24, 2011
Incident venous thromboembolic events in the Prospective Study of Pravastatin in the Elderly at Risk (PROSPER)Dilys J Freeman, Michele Robertson, E Ann Brown, et al.
Cell & Bioscience|March 24, 2024
Enhanced bacterial cancer therapy delivering therapeutic RNA interference of c-MycJason S Williams, Adam T Higgins, Katie J Stott, et al.
Journal of Medical Primatology|May 23, 2007
Preparation and characterization of new challenge stocks of SIVmac32H J5 following rapid serial passage of virus in vivoD Ferguson, A Wade-Evans, W Elsley, et al.
Plos One|September 12, 2013
Long-term effects of statin treatment in elderly people: extended follow-up of the PROspective Study of Pravastatin in the Elderly at Risk (PROSPER)Suzanne M Lloyd, David J Stott, Anton J M de Craen, et al.
Journal of the American Geriatrics Society|January 23, 2014
Homocysteine levels and treatment effect in the PROspective Study of Pravastatin in the Elderly at RiskYvonne M Drewes, Rosalinde K E Poortvliet, Jeanet W Blom, et al.
The American Journal of Medicine|March 16, 2020
The Impact of Levothyroxine on Cardiac Function in Older Adults With Mild Subclinical Hypothyroidism: A Randomized Clinical TrialBaris Gencer, Elisavet Moutzouri, Manuel R Blum, et al.
European Geriatric Medicine|June 22, 2021
Comparing performance on the Months of the Year Backwards test in hospitalised patients with delirium, dementia, and no cognitive impairment: an exploratory studyWolfgang Hasemann, Nikki Duncan, Caoimhe Clarke, et al.
ACS Medicinal Chemistry Letters|January 29, 2016
Potent, Selective, and CNS-Penetrant Tetrasubstituted Cyclopropane Class IIa Histone Deacetylase (HDAC) InhibitorsChristopher A Luckhurst, Perla Breccia, Andrew J Stott, et al.
Pageof 43

Showing results (301-310 of 423) with videos related to

Sort By:
Pageof 43
Pathogens (Basel, Switzerland)|April 30, 2021
Cytokine, Chemokine, and Metalloprotease Activation in the Serum of Patients with Nephropathia Epidemica from the Republic of Tatarstan and the Republic of Mordovia, RussiaEkaterina Martynova, Yuriy Davidyuk, Emmanuel Kabwe, et al.
European Journal of Clinical Pharmacology|December 22, 2015
Non-response to (statin) therapy: the importance of distinguishing non-responders from non-adherers in pharmacogenetic studiesS Trompet, I Postmus, P E Slagboom, et al.
BMC Geriatrics|February 24, 2011
Incident venous thromboembolic events in the Prospective Study of Pravastatin in the Elderly at Risk (PROSPER)Dilys J Freeman, Michele Robertson, E Ann Brown, et al.
Cell & Bioscience|March 24, 2024
Enhanced bacterial cancer therapy delivering therapeutic RNA interference of c-MycJason S Williams, Adam T Higgins, Katie J Stott, et al.
Journal of Medical Primatology|May 23, 2007
Preparation and characterization of new challenge stocks of SIVmac32H J5 following rapid serial passage of virus in vivoD Ferguson, A Wade-Evans, W Elsley, et al.
Plos One|September 12, 2013
Long-term effects of statin treatment in elderly people: extended follow-up of the PROspective Study of Pravastatin in the Elderly at Risk (PROSPER)Suzanne M Lloyd, David J Stott, Anton J M de Craen, et al.
Journal of the American Geriatrics Society|January 23, 2014
Homocysteine levels and treatment effect in the PROspective Study of Pravastatin in the Elderly at RiskYvonne M Drewes, Rosalinde K E Poortvliet, Jeanet W Blom, et al.
The American Journal of Medicine|March 16, 2020
The Impact of Levothyroxine on Cardiac Function in Older Adults With Mild Subclinical Hypothyroidism: A Randomized Clinical TrialBaris Gencer, Elisavet Moutzouri, Manuel R Blum, et al.
European Geriatric Medicine|June 22, 2021
Comparing performance on the Months of the Year Backwards test in hospitalised patients with delirium, dementia, and no cognitive impairment: an exploratory studyWolfgang Hasemann, Nikki Duncan, Caoimhe Clarke, et al.
ACS Medicinal Chemistry Letters|January 29, 2016
Potent, Selective, and CNS-Penetrant Tetrasubstituted Cyclopropane Class IIa Histone Deacetylase (HDAC) InhibitorsChristopher A Luckhurst, Perla Breccia, Andrew J Stott, et al.
Pageof 43